Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,000 across all filing types
Latest filing 2024-07-25 Interim / Quarterly Rep…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
UCB_Half-Year_2024_Report-NL-FINAL.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Halfjaarlijks Financieel Verslag 2024' (Half-Yearly Financial Report 2024) and contains comprehensive financial statements, including a consolidated income statement, balance sheet, cash flow statement, and notes for the six-month period ending June 30, 2024. It includes an auditor's review report ('Verslag van de commissaris') and detailed management discussion of performance. This fits the definition of an Interim/Quarterly Report (IR). H1 2024
2024-07-25 Dutch
240628 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Acquisition of own shares" and explicitly discusses the "Share Repurchase Program 2024". It details the number of shares repurchased, the dates, and the prices paid, concluding that the program has been completed. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is Transaction in Own Shares (POS). The document length is short (2672 chars), but it is a substantive disclosure of a transaction, not merely an announcement of a report's publication, making POS a better fit than RPA or RNS.
2024-06-28 English
240628 - Acquisition actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Rachat d'actions propres" (Share Buyback) and explicitly details the transactions made by UCB SA under its 2024 Share Buyback Program between June 14, 2024, and June 28, 2024. It provides specific dates, quantities of shares repurchased, and the average price paid. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document length is short (2826 chars), but it is a substantive announcement detailing the execution of the program, not just an announcement that a report is available, making POS more specific than RPA or RNS.
2024-06-28 French
240628 - Verwerving van eigen aandelen_NL.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Verwerving van eigen aandelen" (Acquisition of own shares) and details the execution of an 'Aandelen Inkoopprogramma 2024' (Share Buyback Program 2024). It explicitly lists the number of shares purchased, the dates (June 14 to June 28, 2024), and the prices paid. This activity directly corresponds to the company buying back or selling its own shares. This matches the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement of this transaction, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the core transactional data.
2024-06-28 Dutch
240614 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Acquisition of own shares" and explicitly details the repurchase of UCB shares on Euronext Brussels between June 7, 2024, and June 13, 2024, including the number of shares, average price, lowest price, and highest price. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document length is short (2869 chars), but it is a detailed disclosure of the transaction itself, not just an announcement that a report is available, making POS more specific than RPA or RNS.
2024-06-14 English
240614 - Acquisition actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Rachat d'actions propres" (Share Buyback) and explicitly details the number of shares repurchased by UCB on Euronext Brussels between June 7, 2024, and June 13, 2024, including transaction dates, quantities, and prices. This activity directly corresponds to the definition of a company reporting transactions in its own shares. The filing type code 'POS' (Transaction in Own Shares) is the most appropriate classification.
2024-06-14 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.